NewCo News: Start-up biocrea Aims to Bring Phosphodiesterases to Brain
By Anette Breindl
Monday, January 24, 2011
Founded in November 2010, Radebeul, Germany-based biocrea GmbH hopes to be able to make its mark in the midst of what CEO Thomas Kronbach called a "tectonic event" big pharma's retrenchment from central nervous system (CNS) diseases.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.